GET DAILY SIGNALSWhy Is Turning Point Brands (TPB) Stock Down -0.71% Today?
Key Takeaways
- TPB shares fell about 0.71% to $65.41, below the prior session's close of $65.88.
- The primary catalyst was the company's third-quarter earnings release, which beat on revenue and adjusted EPS but showed sharply compressed profitability.
- Revenue climbed 27% to $151.1 million, roughly 2% above consensus, while adjusted EPS of $0.41 topped the $0.35 estimate.
- Investors focused on the downside: adjusted EBITDA fell 41%, net income dropped 81%, and SG&A surged 69% on heavy Modern Oral (nicotine pouch) marketing and freight spending.
- The move unfolded amid broader rotation away from consumer staples and lingering pressure from a recent CEO transition and tightened guidance.
- Traders are watching distribution expansion for the FRE and ALP pouch brands and whether margin pressure eases into 2027.
- For more detail on this company's valuation, results, and outlook, explore the Price Targets, Earnings, and Forecast pages.
- To see how AI-driven strategies are positioning across the market, browse the Trending AI Robots page.
Opening Summary
TPB, or Turning Point Brands, Inc., is a Louisville, Kentucky-based consumer packaged goods company that manufactures and markets tobacco and nicotine products, including Zig-Zag rolling papers, Stoker's moist snuff and loose-leaf tobacco, and the fast-growing FRE and ALP modern oral nicotine pouch brands. The stock traded lower on Monday, slipping about 0.71% to $65.41 from a prior close of $65.88. The decline came as investors digested the company's third-quarter results, which delivered strong top-line growth but revealed meaningful profitability pressure from the company's aggressive investment in its Modern Oral segment.
Earnings-Driven Move: Revenue Beat Overshadowed by Profit Compression
The session's price action was anchored to the company's third-quarter report. TPB posted net sales of $151.1 million, up 27% year over year and modestly ahead of the roughly $148.1 million consensus. Adjusted diluted EPS of $0.41 also came in above the $0.35 estimate. Yet the market reaction was negative, reflecting the profit bridge beneath the headline numbers.
GAAP diluted EPS fell to $0.19 from $1.13 a year earlier, net income declined 81% to $3.9 million, and adjusted EBITDA dropped 41% to $18.4 million. SG&A expenses jumped 69%, driven by sales and marketing investments tied to Modern Oral distribution and brand building, along with higher outbound freight costs. The message to investors was clear: growth is coming at the expense of near-term margins.
Modern Oral Growth at a Cost
The Modern Oral category remains the centerpiece of the company's strategy. Modern Oral gross sales rose 114% year over year, and the segment now accounts for roughly 49% of total revenue, up from about 31% a year earlier. Stoker's net sales climbed 52% to $113.8 million, while Zig-Zag net sales fell 15.5% to $37.3 million.
While the pouch brands FRE and ALP continue to gain traction and distribution, the heavier spending required to scale them—combined with a lower-margin sales mix and the decline in the legacy Zig-Zag business—weighed on profitability. Management reaffirmed its full-year outlook for Modern Oral gross sales of $330 million to $350 million and adjusted EBITDA of $70 million to $80 million, but investors appear focused on the cost of sustaining that trajectory.
Market Context and Trading Activity
The decline in TPB also unfolded within a broader backdrop of investor caution toward consumer staples, as capital rotated toward technology and other growth-oriented sectors. The stock has been trading well below its 52-week high and near the lower end of its range following a recent leadership transition, in which Executive Chairman David Glazek assumed the CEO role after Graham Purdy's departure, alongside a tightening of full-year EBITDA guidance. These company-specific concerns have kept sentiment subdued even as sell-side analysts have maintained generally constructive ratings on the name.
What Comes Next for TPB
Looking ahead, the key question for TPB is whether Modern Oral investments translate into durable, higher-margin growth. Investors will monitor the pace of chain-store distribution expansion, the performance of FRE and ALP against established competitors, and the trajectory of the Zig-Zag business. Upcoming catalysts include the fourth-quarter report and any further updates on the company's U.S. manufacturing plans, which management expects to come online in 2027. Risks include sustained marketing and freight costs, competitive intensity in nicotine pouches, and ongoing margin compression if revenue growth does not convert into profitability.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of the platform's top-performing AI trading bots under current market conditions. Tickeron offers hundreds of AI-driven bots covering thousands of tickers, with strategies that vary by approach, timeframe, performance metrics, and traded symbols. Only the strongest performers are featured in this section, giving traders a streamlined way to explore active, data-driven strategies. Consider browsing the page to see how these tools are positioning across today's markets.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
TPB's RSI Indicator ascending out of oversold territory
The RSI Oscillator for TPB moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 25 of the 31 cases the stock moved higher. This puts the odds of a move higher at 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on TPB as a result. In 55 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for TPB just turned positive on October 07, 2026. Looking at past instances where TPB's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.
TPB moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TPB crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
Following a +5.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where TPB advanced for three days, in 231 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 56 cases where TPB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TPB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
TPB broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TPB entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. TPB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.071) is normal, around the industry mean (-7.297). P/E Ratio (28.154) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (0.048) is also within normal values, averaging (3.595). Dividend Yield (0.005) settles around the average of (0.060) among similar stocks. P/S Ratio (2.701) is also within normal values, averaging (2.780).
The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TPB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of tobacco products
Industry Tobacco
Advertisement